VIRTUAL TRAINING EVENT | Common Off-Target and On-Target Safety Risks in Drug Discovery
Date: 09 June - 10 June 2020
Location: On-Line Event
Tutors: Dr Bryan H. Norman
This is a VIRTUAL short course that will look at drug safety risks that emerge due to the engagement of unintended targets, along with engaging intended targets in unintended tissues
June 09, 3.00 – 4.30 pm (UK) | Session 1
June 10, 3.00 – 4.30 pm (UK) | Session 2
This short course will describe both on- and off-target safety risks and highlight the most common methods used to inform, assess and mitigate risks. Several case studies will be used to bring these issues to life for chemists. Due to the high frequency of drug-induced liver injury (DILI) in clinical development, additional focus on mechanisms and mitigation approaches for this liability will be presented.
When you register you will be sent links to join the on-line sessions. These will take place at the following time each day:
Who should attend this on line course:
This course is specifically designed for chemists. Other members of cross-functional drug discovery teams, such as toxicologists, biologists, pharmacologists, pharmacokineticists and program managers may also gain valuable insights from the content.
3.00 – 5.00 pm | UK
4.00 – 6.00 pm | Central Europe
10.00 – 12.00 | Eastern US
6.00 – 8.00 am | West Coast US
As space is limited there is a small charge of £95.00 + VAT* per person (*only added if your company is based in the UK) Payments only available via credit card.
Virtual Delegate 2020
I really enjoyed the virtual Short Course and it was very good incl. the thorough collection of examples etc.
Looking forward to the next ones!